Biometric information may be extremely useful, but healthcare organizations must take into account state laws before implementing any programs that collect or leverage that information.
Whatever the new source might be, healthcare organizations must have tools available that can assist in the development of IG programs and managing the Big Data influx.
There should be information governance policies and procedures in place that address receipt, processing, and response to subpoenas whether or not these subpoenas call for disclosure of confidential information.
The US Supreme Court has declined to hear a potentially precedent-setting case concerning a privacy breach that exposed the information of 1.1 million CareFirst Blue Cross Blue Shield subscribers in 2014.
The duty of parties in civil actions to “meet-and-confer”—in essence, to cooperate—continues throughout discovery. Unfortunately, cooperation is sometimes lacking.